{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:16:07Z","timestamp":1790972167249,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.lfs.2023.122355","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:20:24Z","timestamp":1702653624000},"page":"122355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury"],"prefix":"10.1016","volume":"337","author":[{"given":"Qian","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0420-0822","authenticated-orcid":false,"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0879-8024","authenticated-orcid":false,"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2023.122355_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2217\/bmm-2020-0691","article-title":"Biomarkers of cholestasis","volume":"15","author":"Alanah","year":"2021","journal-title":"Biomark. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.122355_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2023.122355_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2018.02.002","article-title":"Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity","volume":"824","author":"Kong","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122355_bb0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","article-title":"Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice","volume":"168","author":"Fickert","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122355_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/toxsci\/kfy031","article-title":"Bile acid sequestration by cholestyramine mitigates FGFR4 inhibition-induced ALT elevation","volume":"163","author":"Schadt","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122355_bb0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1248\/bpb.b19-00923","article-title":"Cholestyramine, a bile acid sequestrant, increases cecal short chain fatty acids and intestinal immunoglobulin A in mice","volume":"43","author":"Nishida","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2023.122355_bb0035","series-title":"Obeticholic Acid","author":"Krupa","year":"2023"},{"issue":"1","key":"10.1016\/j.lfs.2023.122355_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1089-3261(03)00135-1","article-title":"Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease","volume":"8","author":"Paumgartner","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.122355_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxlet.2009.03.005","article-title":"Decreased apoptosis during CAR-mediated hepatoprotection against lithocholic acid-induced liver injury in mice","volume":"188","author":"Beilke","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2023.122355_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2015.06.008","article-title":"Hepatoprotective effect of vitamin C on lithocholic acid-induced cholestatic liver injury in Gulo(\u2212\/\u2212) mice","volume":"762","author":"Yu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122355_bb0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/hepr.12150","article-title":"Lithocholic acid-induced placental tumor necrosis factor-\u03b1 upregulation and syncytiotrophoblast cell apoptosis in intrahepatic cholestasis of pregnancy","volume":"44","author":"Du","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.lfs.2023.122355_bb0060","series-title":"Indication: For the Treatment of Primary Biliary Cholangitis (PBC) in Combination with Ursodeoxycholic Acid (UDCA) in Adults with an Inadequate Response to UDCA or as Monotherapy in Adults Unable to Tolerate UDCA, Ottawa (ON)","author":"Clinical Review Report: Obeticholic Acid (Ocaliva): (Intercept Pharmaceuticals Canada, Inc.)","year":"2017"},{"issue":"19","key":"10.1016\/j.lfs.2023.122355_bb0065","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): structures and ligands","volume":"20","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.lfs.2023.122355_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.taap.2016.11.006","article-title":"Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation","volume":"314","author":"Zhang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122355_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2016.07.004","article-title":"Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension","volume":"165","author":"Vignozzi","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122355_bb0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfw098","article-title":"Pyrazinamide induced rat cholestatic liver injury through inhibition of FXR regulatory effect on bile acid synthesis and transport","volume":"152","author":"Guo","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.122355_bb0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2023.122355_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.taap.2018.04.015","article-title":"Yangonin protects against cholestasis and hepatotoxicity via activation of farnesoid X receptor in vivo and in vitro","volume":"348","author":"Gao","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122355_bb0095","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ebiom.2018.10.028","article-title":"Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis","volume":"37","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lfs.2023.122355_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113914","article-title":"Molecular mechanisms of hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: role of FXR and Nrf2 pathways","volume":"178","author":"Cao","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2023.122355_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bcp.2017.09.016","article-title":"Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury","volume":"146","author":"Gao","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122355_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120882","article-title":"Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis","volume":"307","author":"Wang","year":"2022","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.lfs.2023.122355_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.280","article-title":"Activation of necroptosis in human and experimental cholestasis","volume":"7","author":"Afonso","year":"2016","journal-title":"Cell Death Dis."},{"issue":"7813","key":"10.1016\/j.lfs.2023.122355_bb0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2023.122355_bb0125","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3892\/mmr.2020.11210","article-title":"Cholestatic models induced by lithocholic acid and \u03b1-naphthylisothiocyanate: different etiological mechanisms for liver injury but shared JNK\/STAT3 signaling","volume":"22","author":"Xu","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.lfs.2023.122355_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022094","article-title":"Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting","volume":"6","author":"Trottier","year":"2011","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.lfs.2023.122355_bb0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","article-title":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases","volume":"16","author":"Li","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2023.122355_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.329","article-title":"Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytes","volume":"5","author":"Zhang","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"issue":"4","key":"10.1016\/j.lfs.2023.122355_bb0145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/liv.14340","article-title":"Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in nonalcoholic fatty liver disease","volume":"40","author":"Gai","year":"2020","journal-title":"Liver International: official journal of the International Association for the Study of the Liver"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.122355_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2023.122355_bb0155","doi-asserted-by":"crossref","unstructured":"Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Biol Chem 275(15): 10918\u201310924.","DOI":"10.1074\/jbc.275.15.10918"},{"issue":"7","key":"10.1016\/j.lfs.2023.122355_bb0160","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1039\/C9FO00318E","article-title":"Hepatoprotection of auraptene from the peels of citrus fruits against 17alpha-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor","volume":"10","author":"Wang","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2023.122355_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fphar.2019.00048","article-title":"Calculus bovis sativus improves bile acid homeostasis via farnesoid X receptor-mediated signaling in rats with estrogen-induced cholestasis","volume":"10","author":"Xiang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122355_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajpath.2016.09.005","article-title":"Sortilin deficiency reduces ductular reaction, hepatocyte apoptosis, and liver fibrosis in cholestatic-induced liver injury","volume":"187","author":"Hubel","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.lfs.2023.122355_bb0175","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3390\/biomedicines10102464","article-title":"Obeticholic acid for primary biliary cholangitis","volume":"10","author":"Floreani","year":"2022","journal-title":"Biomedicines"},{"issue":"9 Pt B","key":"10.1016\/j.lfs.2023.122355_bb0180","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.bbadis.2018.06.003","article-title":"Interaction of glucocorticoids with FXR\/FGF19\/FGF21-mediated ileum-liver crosstalk","volume":"1864","author":"Al-Aqil","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"10.1016\/j.lfs.2023.122355_bb0185","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.lfs.2023.122355_bb0190","first-page":"1233","article-title":"Methyl jasmonate induces apoptosis through induction of Bax\/Bcl-XS and activation of caspase-3 via ROS production in A549 cells","volume":"12","author":"Kim","year":"2004","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2023.122355_bb0195","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell death: a review of the major forms of apoptosis, necrosis and autophagy","volume":"43","author":"D\u2019Arcy","year":"2019","journal-title":"Cell Biol. Int."},{"issue":"10","key":"10.1016\/j.lfs.2023.122355_bb0200","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.7150\/thno.54072","article-title":"MLKL: functions beyond serving as the executioner of necroptosis","volume":"11","author":"Zhan","year":"2021","journal-title":"Theranostics"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:12:26Z","timestamp":1758402746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523009906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S0024320523009906"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122355","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122355"}}